NCT01703728 - Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old. | Biotech Hunter

Enrollment

455

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Ovarian Hyperstimulation Syndrome (OHSS)

Interventions

OTHER

Highly purified menotropin (HP- hMG) treatment

No intervention: patients treated by highly purified menotropin for COS according to physicians' current practice

Trial Locations (20)

Cabinet Mirabeau Roy René (there may be other sites in this country), Aix-en-Provence

Hôtel Dieu, Angers

Clinique La Chataigneraie, Beaumont

CHU Pellegrin, Bordeaux

Clinique Léonard de Vinci, Chambray-lès-Tours

CHI, Créteil

Hôpital Victor Jousselin, Dreux

Institut Rhonalpin, Écully

Cabinet Médical Maréchal Leclerc, Grenoble

Groupe Hospitalier du Havre - Hôpital Jacques Monod, Le Havre

Cabinet Médical Lille avenue de Dunkerque, Lille

Hôpital Jeanne de Flandre, Lille

Hôpital Privé Natecia, Lyon

CHU de Marseille -Hôpital Conception, Marseille

Hôpital Maternité de Metz, Metz

CHU de Nantes, Nantes

Cabinet Médical de Prony, Paris

Hôpital St Vincent de Paul, Paris

CHU de Rennes, Rennes

Clinique Mutualiste La Sagesse, Rennes